Ketamine 50 mg/ in 0 recalled over sterility concerns
- Recall date
- August 16, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SCA Pharmaceuticals, LLC recalls Ketamine 50 mg/5 mL in 0.9% Sodium Chloride Injection for IV or IM Use (concentration = 10 mg/mL), 6 mL Syringe, Rx Onl…
- Recall number
- D-1843-2019
- FDA classification
- Class II
- Brand / firm
- SCA Pharmaceuticals, LLC
- Sold / distributed
- Nationwide in the U.S.
Why it was recalled
Lack of Assurance of Sterility.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Ketamine 50 mg/5 mL in 0.9% Sodium Chloride Injection for IV or IM Use (concentration = 10 mg/mL), 6 mL Syringe, Rx Only, SCA Pharmaceuticals, Windsor, CT 06095, NDC 70004-0430-09.
Get recall alerts
Free email alert whenever SCA Pharmaceuticals, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SCA Pharmaceuticals, LLC